Skip to main content
Springer Nature Link
Log in

Tourette Syndrome Treatment Updates: a Review and Discussion of the Current and Upcoming Literature

  • Movement Disorders (T. Simuni, Section Editor)
  • Published:
Save article
View saved research
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

This study aims to examine the treatments currently available for Tourette syndrome (TS) and to discuss evolving therapies, spanning behavioral, pharmacologic, complementary and alternative medicine, and neuromodulation approaches.

Recent Findings

Behavioral therapies have undergone several modifications to improve accessibility, including transitioning to a virtual format which is particularly important in the current pandemic. There are several recent or ongoing pharmacologic studies that have shown promise including the selective D1 receptor antagonist ecopipam and various cannabinoid compounds. Adaptive DBS may enable the physiologic markers of tics to determine stimulation parameters and improve tic outcomes related to neuromodulation.

Summary

In recent years, there has been a wealth of research across multiple treatment domains in the TS field. This review highlights exciting and new potential options for the future treatment of patients with TS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+
from $39.99 /Month
  • Starting from 10 chapters or articles per month
  • Access and download chapters and articles from more than 300k books and 2,500 journals
  • Cancel anytime
View plans

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Explore related subjects

Discover the latest articles, books and news in related subjects, suggested using machine learning.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Yadegar M, Guo S, Ricketts EJ, Zinner SH. Assessment and management of tic disorders in pediatric primary care settings. Curr Dev Disord Rep. 2019;6(3):159–72. https://doi.org/10.1007/s40474-019-00168-8.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Nussey C, Pistrang N, Murphy T. How does psychoeducation help? A review of the effects of providing information about Tourette syndrome and attention-deficit/hyperactivity disorder. Child Care Health Dev. 2013;39(5):617–27. https://doi.org/10.1111/cch.12039.

    Article  CAS  PubMed  Google Scholar 

  3. Chistol A LO. The role of family psychoeducation in the management of tics and tic-related impairment in grade school children. Abstracts of the ENCP Workshop for Junior Scientists. 2018.

  4. Cen SS, Yu J, Wang Q, Deeb W, Wang KL, Shukla AW, et al. Multidisciplinary telemedicine care for Tourette syndrome: minireview. Front Neurol. 2020;11: 573576. https://doi.org/10.3389/fneur.2020.573576.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Conte G, Valente F, Fioriello F, Cardona F. Rage attacks in Tourette syndrome and chronic tic disorder: a systematic review. Neurosci Biobehav Rev. 2020;119:21–36. https://doi.org/10.1016/j.neubiorev.2020.09.019.

    Article  PubMed  Google Scholar 

  6. Cauberghe V, Van Wesenbeeck I, De Jans S, Hudders L, Ponnet K. How adolescents use social media to cope with feelings of loneliness and anxiety during COVID-19 lockdown. Cyberpsychol Behav Soc Netw. 2021;24(4):250–7. https://doi.org/10.1089/cyber.2020.0478.

    Article  PubMed  Google Scholar 

  7. Heyman I, Liang H, Hedderly T. COVID-19 related increase in childhood tics and tic-like attacks. Arch Dis Child. 2021. https://doi.org/10.1136/archdischild-2021-321748.

    Article  PubMed  Google Scholar 

  8. Perkins V, Coulson NS, Davies EB. Using online support communities for Tourette syndrome and tic disorders: online survey of users' experiences. J Med Internet Res. 2020;22(11):e18099. https://doi.org/10.2196/18099.

  9. •• Pringsheim T, Okun MS, Müller-Vahl K, Martino D, Jankovic J, Cavanna AE et al. Practice guideline recommendations summary: treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology. 2019;92(19):896-906. doi:https://doi.org/10.1212/WNL.0000000000007466. Most recent AAN practice guidelines for the treatment of TS

  10. •• Andrén P, Jakubovski E, Murphy TL, Woitecki K, Tarnok Z, Zimmerman-Brenner S et al. European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part II: psychological interventions. Eur Child Adolesc Psychiatry. 2021. https://doi.org/10.1007/s00787-021-01845-z. Most recent European guidelines for the treatment of TS

  11. Liu S, Li Y, Cui Y. Review of habit reversal training for tic disorders. Pediatr Investig. 2020;4(2):127–32. https://doi.org/10.1002/ped4.12190.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Wu MS, McGuire JF. Psychoeducation about tic disorders and treatment. The clinician's guide to treatment and management of youth with Tourette syndrome and tic disorder. San Diego, CA, US: Elsevier Academic Press; 2018. p. 21–41.

  13. •• Pringsheim T, Holler-Managan Y, Okun MS, Jankovic J, Piacentini J, Cavanna AE et al. Comprehensive systematic review summary: treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology. 2019;92(19):907-15. doi:https://doi.org/10.1212/WNL.0000000000007467.  Recent systematic review that covers many details about efficacy and safety of treatments for TS

  14. •• Steeves T, McKinlay BD, Gorman D, Billinghurst L, Day L, Carroll A, et al. Canadian guidelines for the evidence-based treatment of tic disorders: behavioural therapy, deep brain stimulation, and transcranial magnetic stimulation. Can J Psychiatry. 2012;57(3):144–51. https://doi.org/10.1177/070674371205700303. Most recent Canadian guidelines for the treatment of TS

  15. Rizzo R, Pellico A, Silvestri PR, Chiarotti F, Cardona F. A randomized controlled trial comparing behavioral, educational, and pharmacological treatments in youths with chronic tic disorder or Tourette syndrome. Front Psychiatry. 2018;9:100. https://doi.org/10.3389/fpsyt.2018.00100.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Kim KM, Bae E, Lee J, Park TW, Lim MH. A review of cognitive and behavioral interventions for tic disorder. Soa Chongsonyon Chongsin Uihak. 2021;32(2):51–62. https://doi.org/10.5765/jkacap.200042.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Robertson MM. Gilles de la Tourette syndrome: the complexities of phenotype and treatment. Br J Hosp Med (Lond). 2011;72(2):100–7. https://doi.org/10.12968/hmed.2011.72.2.100.

    Article  Google Scholar 

  18. Verdellen CW, Keijsers GP, Cath DC, Hoogduin CA. Exposure with response prevention versus habit reversal in Tourette’s syndrome: a controlled study. Behav Res Ther. 2004;42(5):501–11. https://doi.org/10.1016/S0005-7967(03)00154-2.

    Article  PubMed  Google Scholar 

  19. Deckersbach T, Rauch S, Buhlmann U, Wilhelm S. Habit reversal versus supportive psychotherapy in Tourette’s disorder: a randomized controlled trial and predictors of treatment response. Behav Res Ther. 2006;44(8):1079–90. https://doi.org/10.1016/j.brat.2005.08.007.

    Article  PubMed  Google Scholar 

  20. Wilhelm S, Deckersbach T, Coffey BJ, Bohne A, Peterson AL, Baer L. Habit reversal versus supportive psychotherapy for Tourette’s disorder: a randomized controlled trial. Am J Psychiatry. 2003;160(6):1175–7. https://doi.org/10.1176/appi.ajp.160.6.1175.

    Article  PubMed  Google Scholar 

  21. O’Connor KP, Brault M, Robillard S, Loiselle J, Borgeat F, Stip E. Evaluation of a cognitive-behavioural program for the management of chronic tic and habit disorders. Behav Res Ther. 2001;39(6):667–81. https://doi.org/10.1016/s0005-7967(00)00048-6.

    Article  CAS  PubMed  Google Scholar 

  22. Seragni G, Chiappedi M, Bettinardi B, Zibordi F, Colombo T, Reina C, et al. Habit reversal training in children and adolescents with chronic tic disorders: an Italian randomized, single-blind pilot study. Minerva Pediatr. 2018;70(1):5–11. https://doi.org/10.23736/S0026-4946.16.04344-9.

    Article  PubMed  Google Scholar 

  23. Viefhaus P, Feldhausen M, Görtz-Dorten A, Volk H, Döpfner M, Woitecki K. Efficacy of habit reversal training in children with chronic tic disorders: a within-subject analysis. Behav Modif. 2020;44(1):114–36. https://doi.org/10.1177/0145445518796203.

    Article  PubMed  Google Scholar 

  24. McGuire JF, Piacentini J, Scahill L, Woods DW, Villarreal R, Wilhelm S, et al. Bothersome tics in patients with chronic tic disorders: characteristics and individualized treatment response to behavior therapy. Behav Res Ther. 2015;70:56–63. https://doi.org/10.1016/j.brat.2015.05.006.

    Article  PubMed  PubMed Central  Google Scholar 

  25. McGinty HLDNA, Park JM, Storch EA. Living with tics: a cognitive-behavioral approach to improving coping and reducing tic severity in a young adult with Tourette disorder. Clin Case Stud. 2012;11(3):218–33.

    Article  Google Scholar 

  26. Scahill L, Woods DW, Himle MB, Peterson AL, Wilhelm S, Piacentini JC, et al. Current controversies on the role of behavior therapy in Tourette syndrome. Mov Disord. 2013;28(9):1179–83. https://doi.org/10.1002/mds.25488.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Petruo V, Bodmer B, Bluschke A, Münchau A, Roessner V, Beste C. Comprehensive behavioral intervention for tics reduces perception-action binding during inhibitory control in Gilles de la Tourette syndrome. Sci Rep. 2020;10(1):1174. https://doi.org/10.1038/s41598-020-58269-z.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Woods DW, Piacentini JC, Scahill L, Peterson AL, Wilhelm S, Chang S, et al. Behavior therapy for tics in children: acute and long-term effects on psychiatric and psychosocial functioning. J Child Neurol. 2011;26(7):858–65. https://doi.org/10.1177/0883073810397046.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Wilhelm S, Peterson AL, Piacentini J, Woods DW, Deckersbach T, Sukhodolsky DG, et al. Randomized trial of behavior therapy for adults with Tourette syndrome. Arch Gen Psychiatry. 2012;69(8):795–803. https://doi.org/10.1001/archgenpsychiatry.2011.1528.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Piacentini J, Woods DW, Scahill L, Wilhelm S, Peterson AL, Chang S, et al. Behavior therapy for children with Tourette disorder: a randomized controlled trial. JAMA. 2010;303(19):1929–37. https://doi.org/10.1001/jama.2010.607.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Espil F. A long term follow up to a randomized controlled trial of comprehensive behavioral intervention for tics: University of Wisconsin-Milwaukee; 2015.

  32. McGuire JF, Ricketts EJ, Scahill L, Wilhelm S, Woods DW, Piacentini J, et al. Effect of behavior therapy for Tourette’s disorder on psychiatric symptoms and functioning in adults. Psychol Med. 2020;50(12):2046–56. https://doi.org/10.1017/S0033291719002150.

    Article  PubMed  Google Scholar 

  33. Bennett SM, Capriotti M, Bauer C, Chang S, Keller AE, Walkup J, et al. Development and open trial of a psychosocial intervention for young children with chronic tics: the CBIT-JR Study. Behav Ther. 2020;51(4):659–69. https://doi.org/10.1016/j.beth.2019.10.004.

    Article  PubMed  Google Scholar 

  34. Singer HS, McDermott S, Ferenc L, Specht M, Mahone EM. Efficacy of parent-delivered, home-based therapy for tics. Pediatr Neurol. 2020;106:17–23. https://doi.org/10.1016/j.pediatrneurol.2019.12.015.

    Article  PubMed  Google Scholar 

  35. Yates R, Edwards K, King J, Luzon O, Evangeli M, Stark D, et al. Habit reversal training and educational group treatments for children with Tourette syndrome: a preliminary randomised controlled trial. Behav Res Ther. 2016;80:43–50. https://doi.org/10.1016/j.brat.2016.03.003.

    Article  PubMed  Google Scholar 

  36. Dabrowski J, King J, Edwards K, Yates R, Heyman I, Zimmerman-Brenner S, et al. The long-term effects of group-based psychological interventions for children with Tourette syndrome: a randomized controlled trial. Behav Ther. 2018;49(3):331–43. https://doi.org/10.1016/j.beth.2017.10.005.

    Article  PubMed  Google Scholar 

  37. Nissen JB, Kaergaard M, Laursen L, Parner E, Thomsen PH. Combined habit reversal training and exposure response prevention in a group setting compared to individual training: a randomized controlled clinical trial. Eur Child Adolesc Psychiatry. 2019;28(1):57–68. https://doi.org/10.1007/s00787-018-1187-z.

    Article  PubMed  Google Scholar 

  38. Heijerman-Holtgrefe AP, Verdellen CWJ, van de Griendt JMTM, Beljaars LPL, Kan KJ, Cath D, et al. Tackle your tics: pilot findings of a brief, intensive group-based exposure therapy program for children with tic disorders. Eur Child Adolesc Psychiatry. 2021;30(3):461–73. https://doi.org/10.1007/s00787-020-01532-5.

    Article  CAS  PubMed  Google Scholar 

  39. Leclerc JB, O'Connor KP, J-Nolin G, Valois P, Lavoie ME. The effect of a new therapy for children with tics targeting underlying cognitive, behavioral, and physiological processes. Front Psychiatry. 2016;7:135. doi:https://doi.org/10.3389/fpsyt.2016.00135.

  40. O’Connor K, Lavoie M, Blanchet P, St-Pierre-Delorme M. Evaluation of a cognitive psychophysiological model for management of tic disorders: an open trial. Br J Psychiatry. 2016;209(1):76–83. https://doi.org/10.1192/bjp.bp.114.154518.

    Article  PubMed  Google Scholar 

  41. Chen CW, Wang HS, Chang HJ, Hsueh CW. Effectiveness of a modified comprehensive behavioral intervention for tics for children and adolescents with Tourette’s syndrome: a randomized controlled trial. J Adv Nurs. 2020;76(3):903–15. https://doi.org/10.1111/jan.14279.

    Article  PubMed  Google Scholar 

  42. Blount THRJ, Peterson AL. Intensive outpatient comprehensive behavioral intervention for tics: a clinical replication series. Cogn Behav Pract. 2017;25(1):156–67.

    Article  Google Scholar 

  43. Blount TH, Lockhart AL, Garcia RV, Raj JJ, Peterson AL. Intensive outpatient comprehensive behavioral intervention for tics: a case series. World J Clin Cases. 2014;2(10):569–77. https://doi.org/10.12998/wjcc.v2.i10.569.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Himle MB, Freitag M, Walther M, Franklin SA, Ely L, Woods DW. A randomized pilot trial comparing videoconference versus face-to-face delivery of behavior therapy for childhood tic disorders. Behav Res Ther. 2012;50(9):565–70. https://doi.org/10.1016/j.brat.2012.05.009.

    Article  PubMed  Google Scholar 

  45. Ricketts EJ, Goetz AR, Capriotti MR, Bauer CC, Brei NG, Himle MB, et al. A randomized waitlist-controlled pilot trial of voice over Internet protocol-delivered behavior therapy for youth with chronic tic disorders. J Telemed Telecare. 2016;22(3):153–62. https://doi.org/10.1177/1357633X15593192.

    Article  PubMed  Google Scholar 

  46. Andrén P, Aspvall K, Fernández de la Cruz L, Wiktor P, Romano S, Andersson E et al. Therapist-guided and parent-guided internet-delivered behaviour therapy for paediatric Tourette's disorder: a pilot randomised controlled trial with long-term follow-up. BMJ Open. 2019;9(2):e024685. doi:https://doi.org/10.1136/bmjopen-2018-024685.

  47. Conelea CA, Wellen BCM. Tic treatment goes tech: a review of TicHelper.com. Cogn Behav Pract. 2017;24(3):374–81. doi:https://doi.org/10.1016/j.cbpra.2017.01.003.

  48. Black JK, Koller JM, Black KJ. TicTimer software for measuring tic suppression. F1000Res. 2017;6:1560. doi:https://doi.org/10.12688/f1000research.12327.2.

  49. Hall CL, Davies EB, Andrén P, Murphy T, Bennett S, Brown BJ, et al. Investigating a therapist-guided, parent-assisted remote digital behavioural intervention for tics in children and adolescents-’Online Remote Behavioural Intervention for Tics’ (ORBIT) trial: protocol of an internal pilot study and single-blind randomised controlled trial. BMJ Open. 2019;9(1): e027583. https://doi.org/10.1136/bmjopen-2018-027583.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Jakubovski E, Reichert C, Karch A, Buddensiek N, Breuer D, Müller-Vahl K. The ONLINE-TICS study protocol: a randomized observer-blind clinical trial to demonstrate the efficacy and safety of Internet-delivered behavioral treatment for adults with chronic tic disorders. Front Psychiatry. 2016;7:119. https://doi.org/10.3389/fpsyt.2016.00119.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Hawksley J, Cavanna AE, Nagai Y. The role of the autonomic nervous system in Tourette syndrome. Front Neurosci. 2015;9:117. https://doi.org/10.3389/fnins.2015.00117.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Nagai Y, Cavanna AE, Critchley HD, Stern JJ, Robertson MM, Joyce EM. Biofeedback treatment for Tourette syndrome: a preliminary randomized controlled trial. Cogn Behav Neurol. 2014;27(1):17–24. https://doi.org/10.1097/WNN.0000000000000019.

    Article  PubMed  Google Scholar 

  53. Nagai Y, Cavanna A, Critchley HD. Influence of sympathetic autonomic arousal on tics: implications for a therapeutic behavioral intervention for Tourette syndrome. J Psychosom Res. 2009;67(6):599–605. https://doi.org/10.1016/j.jpsychores.2009.06.004.

    Article  PubMed  Google Scholar 

  54. Sukhodolsky DG, Walsh C, Koller WN, Eilbott J, Rance M, Fulbright RK, et al. Randomized, sham-controlled trial of real-time functional magnetic resonance imaging neurofeedback for tics in adolescents with Tourette syndrome. Biol Psychiatry. 2020;87(12):1063–70. https://doi.org/10.1016/j.biopsych.2019.07.035.

    Article  PubMed  Google Scholar 

  55. Seideman MF, Seideman TA. A review of the current treatment of Tourette syndrome.J Pediatr Pharmacol Ther. 2020;25(5):401-12. doi:https://doi.org/10.5863/1551-6776-25.5.401. 

  56. • Ueda K, Black KJ. A comprehensive review of tic disorders in children. J Clin Med. 2021;10(11). https://doi.org/10.3390/jcm10112479. This paper gives a good overview of various different treatments for tic disorders in general

  57. • Essoe JK, Grados MA, Singer HS, Myers NS, McGuire JF. Evidence-based treatment of Tourette’s disorder and chronic tic disorders. Expert Rev Neurother. 2019;19(11):1103–15. https://doi.org/10.1080/14737175.2019.1643236. Similarly, this paper discusses multiple aspects of treatments for tic disorders

  58. Goetz CG, Tanner CM, Wilson RS, Carroll VS, Como PG, Shannon KM. Clonidine and Gilles de la Tourette’s syndrome: double-blind study using objective rating methods. Ann Neurol. 1987;21(3):307–10. https://doi.org/10.1002/ana.410210313.

    Article  CAS  PubMed  Google Scholar 

  59. Leckman JF, Hardin MT, Riddle MA, Stevenson J, Ort SI, Cohen DJ. Clonidine treatment of Gilles de la Tourette’s syndrome. Arch Gen Psychiatry. 1991;48(4):324–8. https://doi.org/10.1001/archpsyc.1991.01810280040006.

    Article  CAS  PubMed  Google Scholar 

  60. Group TsSS. Treatment of ADHD in children with tics: a randomized controlled trial. Neurology. 2002;58(4):527–36. https://doi.org/10.1212/wnl.58.4.527.

    Article  Google Scholar 

  61. Du YS, Li HF, Vance A, Zhong YQ, Jiao FY, Wang HM, et al. Randomized double-blind multicentre placebo-controlled clinical trial of the clonidine adhesive patch for the treatment of tic disorders. Aust N Z J Psychiatry. 2008;42(9):807–13. https://doi.org/10.1080/00048670802277222.

    Article  PubMed  Google Scholar 

  62. Song PP, Jiang L, Li XJ, Hong SQ, Li SZ, Hu Y. The efficacy and tolerability of the clonidine transdermal patch in the treatment for children with tic disorders: a prospective, open, single-group, self-controlled study. Front Neurol. 2017;8:32. https://doi.org/10.3389/fneur.2017.00032.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Yang C, Kang B, Yu D, Zhao L, Zhang L. Effectiveness and safety of a clonidine adhesive patch for children with tic disorders: study in a real-world practice. Front Neurol. 2020;11:361. https://doi.org/10.3389/fneur.2020.00361.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Kang H, Zhang YF, Jiao FY, Guo XY, Gao XM. Efficacy of clonidine transdermal patch for treatment of Tourette’s syndrome in children. Zhongguo Dang Dai Er Ke Za Zhi. 2009;11(7):537–9.

    PubMed  Google Scholar 

  65. Jiao F, Zhang X, Wang J. Clinical observation on treatment of Tourette syndrome in Chinese children by clonidine adhesive patch. Eur J Paediatr Neurol. 2016;20(1):80–4. https://doi.org/10.1016/j.ejpn.2015.10.002.

    Article  PubMed  Google Scholar 

  66. Guo JM, Shi XX, Yang SW, Qian QF, Huang Y, Xie YQ, et al. Efficacy of clonidine transdermal patch in treatment of moderate to severe tic disorders in children. Zhongguo Dang Dai Er Ke Za Zhi. 2017;19(7):786–9.

    PubMed  Google Scholar 

  67. Boon-yasidhi V, Kim YS, Scahill L. An open-label, prospective study of guanfacine in children with ADHD and tic disorders. J Med Assoc Thai. 2005;88(Suppl 8):S156–62.

    PubMed  Google Scholar 

  68. Scahill L, Chappell PB, Kim YS, Schultz RT, Katsovich L, Shepherd E, et al. A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. Am J Psychiatry. 2001;158(7):1067–74. https://doi.org/10.1176/appi.ajp.158.7.1067.

    Article  CAS  PubMed  Google Scholar 

  69. Cummings DD, Singer HS, Krieger M, Miller TL, Mahone EM. Neuropsychiatric effects of guanfacine in children with mild Tourette syndrome: a pilot study. Clin Neuropharmacol. 2002;25(6):325–32. https://doi.org/10.1097/00002826-200211000-00009.

    Article  CAS  PubMed  Google Scholar 

  70. Murphy TK, Fernandez TV, Coffey BJ, Rahman O, Gavaletz A, Hanks CE, et al. Extended-release guanfacine does not show a large effect on tic severity in children with chronic tic disorders. J Child Adolesc Psychopharmacol. 2017;27(9):762–70. https://doi.org/10.1089/cap.2017.0024.

    Article  CAS  PubMed  Google Scholar 

  71. Martínez-Granero MA, García-Pérez A, Montañes F. Levetiracetam as an alternative therapy for Tourette syndrome. Neuropsychiatr Dis Treat. 2010;6:309–16. https://doi.org/10.2147/ndt.s6371.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Jankovic J, Jimenez-Shahed J, Brown LW. A randomised, double-blind, placebo-controlled study of topiramate in the treatment of Tourette syndrome. J Neurol Neurosurg Psychiatry. 2010;81(1):70–3. https://doi.org/10.1136/jnnp.2009.185348.

    Article  CAS  PubMed  Google Scholar 

  73. Kuo SH, Jimenez-Shahed J. Topiramate in treatment of Tourette syndrome. Clin Neuropharmacol. 2010;33(1):32–4. https://doi.org/10.1097/WNF.0b013e3181c295c1.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  74. Awaad YMA, Minarik S. Long-term use of levetiracetam to treat tics in children and adolescents with Tourette syndrome. J Ped Neurol. 2007;5(3):209–14.

  75. Smith-Hicks CL, Bridges DD, Paynter NP, Singer HS. A double blind randomized placebo control trial of levetiracetam in Tourette syndrome. Mov Disord. 2007;22(12):1764–70. https://doi.org/10.1002/mds.21615.

    Article  PubMed  Google Scholar 

  76. Hedderick EF, Morris CM, Singer HS. Double-blind, crossover study of clonidine and levetiracetam in Tourette syndrome. Pediatr Neurol. 2009;40(6):420-5. doi:https://doi.org/10.1016/j.pediatrneurol.2008.12.014. 

  77. • Quezada J, Coffman KA. Current approaches and new developments in the pharmacological management of Tourette syndrome. CNS Drugs. 2018;32(1):33–45. https://doi.org/10.1007/s40263-017-0486-0. A comprehensive overview of the pharmacotherapies used to treat TS

  78. Singer HS, Wendlandt J, Krieger M, Giuliano J. Baclofen treatment in Tourette syndrome: a double-blind, placebo-controlled, crossover trial. Neurology. 2001;56(5):599–604. https://doi.org/10.1212/wnl.56.5.599.

    Article  CAS  PubMed  Google Scholar 

  79. Deeb W, Malaty IA, Mathews CA. Tourette disorder and other tic disorders. Handb Clin Neurol. 2019;165:123–53. https://doi.org/10.1016/B978-0-444-64012-3.00008-3.

    Article  PubMed  Google Scholar 

  80. Gulisano M, Calì PV, Cavanna AE, Eddy C, Rickards H, Rizzo R. Cardiovascular safety of aripiprazole and pimozide in young patients with Tourette syndrome. Neurol Sci. 2011;32(6):1213–7. https://doi.org/10.1007/s10072-011-0678-1.

    Article  PubMed  Google Scholar 

  81. Yang C, Yi Q, Zhang L, Cui H, Mao J. Safety of aripiprazole for tics in children and adolescents: a systematic review and meta-analysis. Medicine (Baltimore). 2019;98(22): e15816. https://doi.org/10.1097/MD.0000000000015816.

    Article  Google Scholar 

  82. Yang CS, Huang H, Zhang LL, Zhu CR, Guo Q. Aripiprazole for the treatment of tic disorders in children: a systematic review and meta-analysis. BMC Psychiatry. 2015;15:179. https://doi.org/10.1186/s12888-015-0504-z.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  83. Tao D, Zhong T, Ma S, Li J, Li X. Randomized controlled clinical trial comparing the efficacy and tolerability of aripiprazole and sodium valproate in the treatment of Tourette syndrome. Ann Gen Psychiatry. 2019;18:24. https://doi.org/10.1186/s12991-019-0245-3.

    Article  PubMed  PubMed Central  Google Scholar 

  84. Budman CL. The role of atypical antipsychotics for treatment of Tourette’s syndrome: an overview. Drugs. 2014;74(11):1177–93. https://doi.org/10.1007/s40265-014-0254-0.

    Article  CAS  PubMed  Google Scholar 

  85. Gilbert DL, Budman CL, Singer HS, Kurlan R, Chipkin RE. A D1 receptor antagonist, ecopipam, for treatment of tics in Tourette syndrome. Clin Neuropharmacol. 2014;37(1):26–30. https://doi.org/10.1097/WNF.0000000000000017.

    Article  CAS  PubMed  Google Scholar 

  86. Gilbert DL, Murphy TK, Jankovic J, Budman CL, Black KJ, Kurlan RM, et al. Ecopipam, a D1 receptor antagonist, for treatment of Tourette syndrome in children: a randomized, placebo-controlled crossover study. Mov Disord. 2018;33(8):1272–80. https://doi.org/10.1002/mds.27457.

    Article  CAS  PubMed  Google Scholar 

  87. Jankovic J, Glaze DG, Frost JD. Effect of tetrabenazine on tics and sleep of Gilles de la Tourette’s syndrome. Neurology. 1984;34(5):688–92. https://doi.org/10.1212/wnl.34.5.688.

    Article  CAS  PubMed  Google Scholar 

  88. Kenney C, Hunter C, Jankovic J. Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders. Mov Disord. 2007;22(2):193–7. https://doi.org/10.1002/mds.21222.

    Article  PubMed  Google Scholar 

  89. Jankovic J, Jimenez-Shahed J, Budman C, Coffey B, Murphy T, Shprecher D, et al. Deutetrabenazine in tics associated with Tourette syndrome. Tremor Other Hyperkinet Mov (N Y). 2016;6:422. https://doi.org/10.7916/D8M32W3H.

    Article  Google Scholar 

  90. Farber RH, Angelov A, Kim K, Carmack T, Thai-Cuarto D, Roberts E. Clinical development of valbenazine for tics associated with Tourette syndrome. Expert Rev Neurother. 2021;21(4):393–404. https://doi.org/10.1080/14737175.2021.1898948.

    Article  CAS  PubMed  Google Scholar 

  91. Szejko N, Jakubovski E, Muller-Vahl K. Possible role of the endocannabinoid system in Tourette syndrome. Recent Advances in Cannabinoid Research. IntechOpen; 2018.

  92. Müller-Vahl KR, Schneider U, Koblenz A, Jöbges M, Kolbe H, Daldrup T, et al. Treatment of Tourette’s syndrome with Delta 9-tetrahydrocannabinol (THC): a randomized crossover trial. Pharmacopsychiatry. 2002;35(2):57–61. https://doi.org/10.1055/s-2002-25028.

    Article  PubMed  Google Scholar 

  93. Müller-Vahl KR, Schneider U, Prevedel H, Theloe K, Kolbe H, Daldrup T, et al. Delta 9-tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome: a 6-week randomized trial. J Clin Psychiatry. 2003;64(4):459–65. https://doi.org/10.4088/jcp.v64n0417.

    Article  PubMed  Google Scholar 

  94. Curtis A, Clarke CE, Rickards HE. Cannabinoids for Tourette's syndrome. Cochrane Database Syst Rev. 2009(4):CD006565. doi:https://doi.org/10.1002/14651858.CD006565.pub2.

  95. Artukoglu BB, Bloch MH. The potential of cannabinoid-based treatments in Tourette syndrome. CNS Drugs. 2019;33(5):417–30. https://doi.org/10.1007/s40263-019-00627-1.

    Article  CAS  PubMed  Google Scholar 

  96. Milosev LM, Psathakis N, Szejko N, Jakubovski E, Müller-Vahl KR. Treatment of Gilles de la Tourette syndrome with cannabis-based medicine: results from a retrospective analysis and online survey. Cannabis Cannabinoid Res. 2019;4(4):265–74. https://doi.org/10.1089/can.2018.0050.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  97. Jakubovski E, Pisarenko A, Fremer C, Haas M, May M, Schumacher C, et al. The CANNA-TICS study protocol: a randomized multi-center double-blind placebo controlled trial to demonstrate the efficacy and safety of nabiximols in the treatment of adults with chronic tic disorders. Front Psychiatry. 2020;11: 575826. https://doi.org/10.3389/fpsyt.2020.575826.

    Article  PubMed  PubMed Central  Google Scholar 

  98. Mueller-Vahl K. ABX-1431, a first-in-class endocannabinoid modulator, improves tics in adult patients with Tourette syndrome. Neurology. 2018;90:e2182–3.

    Google Scholar 

  99. Müller-Vahl KR, Fremer C, Beals C, Ivkovic J, Loft H, Schindler C. Monoacylglycerol lipase inhibition in Tourette syndrome: a 12-week, randomized, controlled study. Mov Disord. 2021;36(10):2413–8. https://doi.org/10.1002/mds.28681.

    Article  CAS  PubMed  Google Scholar 

  100. Bloch MH, Landeros-Weisenberger A, Johnson JA, Leckman JF. A phase-2 pilot study of a therapeutic combination of Δ. J Neuropsychiatry Clin Neurosci. 2021;33(4):328–36. https://doi.org/10.1176/appi.neuropsych.19080178.

    Article  PubMed  Google Scholar 

  101. Aguirregomozcorta M, Pagonabarraga J, Diaz-Manera J, Pascual-Sedano B, Gironell A, Kulisevsky J. Efficacy of botulinum toxin in severe Tourette syndrome with dystonic tics involving the neck. Parkinsonism Relat Disord. 2008;14(5):443–5. https://doi.org/10.1016/j.parkreldis.2007.10.007.

    Article  PubMed  Google Scholar 

  102. Trimble MR, Whurr R, Brookes G, Robertson MM. Vocal tics in Gilles de la Tourette syndrome treated with botulinum toxin injections. Mov Disord. 1998;13(3):617–9. https://doi.org/10.1002/mds.870130348.

    Article  CAS  PubMed  Google Scholar 

  103. Scott BL, Jankovic J, Donovan DT. Botulinum toxin injection into vocal cord in the treatment of malignant coprolalia associated with Tourette’s syndrome. Mov Disord. 1996;11(4):431–3. https://doi.org/10.1002/mds.870110413.

    Article  CAS  PubMed  Google Scholar 

  104. Salloway S, Stewart CF, Israeli L, Morales X, Rasmussen S, Blitzer A, et al. Botulinum toxin for refractory vocal tics. Mov Disord. 1996;11(6):746–8. https://doi.org/10.1002/mds.870110627.

    Article  CAS  PubMed  Google Scholar 

  105. Jankovic J. Botulinum toxin in the treatment of dystonic tics. Mov Disord. 1994;9(3):347–9. https://doi.org/10.1002/mds.870090315.

    Article  CAS  PubMed  Google Scholar 

  106. Kwak CH, Hanna PA, Jankovic J. Botulinum toxin in the treatment of tics. Arch Neurol. 2000;57(8):1190–3. https://doi.org/10.1001/archneur.57.8.1190.

    Article  CAS  PubMed  Google Scholar 

  107. Porta M, Maggioni G, Ottaviani F, Schindler A. Treatment of phonic tics in patients with Tourette’s syndrome using botulinum toxin type A. Neurol Sci. 2004;24(6):420–3. https://doi.org/10.1007/s10072-003-0201-4.

    Article  CAS  PubMed  Google Scholar 

  108. Rath JJ, Tavy DL, Wertenbroek AA, van Woerkom TC, de Bruijn SF. Botulinum toxin type A in simple motor tics: short-term and long-term treatment-effects. Parkinsonism Relat Disord. 2010;16(7):478–81. https://doi.org/10.1016/j.parkreldis.2009.11.011.

    Article  PubMed  Google Scholar 

  109. Marras C, Andrews D, Sime E, Lang AE. Botulinum toxin for simple motor tics: a randomized, double-blind, controlled clinical trial. Neurology. 2001;56(5):605–10. https://doi.org/10.1212/wnl.56.5.605.

    Article  CAS  PubMed  Google Scholar 

  110. Pandey S, Srivanitchapoom P, Kirubakaran R, Berman BD. Botulinum toxin for motor and phonic tics in Tourette's syndrome. Cochrane Database Syst Rev. 2018;1:CD012285. doi:https://doi.org/10.1002/14651858.CD012285.pub2.

  111. Patel H, Nguyen K, Lehman E, Mainali G, Duda L, Byler D, et al. Use of complementary and alternative medicine in children with Tourette syndrome. J Child Neurol. 2020;35(8):512–6. https://doi.org/10.1177/0883073820913670.

    Article  PubMed  Google Scholar 

  112. Qi H, Liu R, Zheng W, Zhang L, Ungvari GS, Ng CH et al. Efficacy and safety of traditional Chinese medicine for Tourette's syndrome: a meta-analysis of randomized controlled trials. Asian J Psychiatr. 2020;47:101853. https://doi.org/10.1016/j.ajp.2019.101853. 

  113. • Wang N, Qin DD, Xie YH, Wu XC, Wang DY, Hang-Yang et al. Traditional Chinese medicine strategy for patients with Tourette syndrome based on clinical efficacy and safety: a meta-analysis of 47 randomized controlled trials. Biomed Res Int. 2021;2021:6630598. https://doi.org/10.1155/2021/6630598. Overview of various TCM approaches forthe treatment of TS

  114. Lv J, Zhu Q, Hao Y. The treatment of Choudongning capsule in children with Tourette’s syndrome: a double blind and double simulation clinical study (in Chinese). Global Tradit Chin Med. 2013;6:85–6.

    Google Scholar 

  115. Yang N, Ma R, Hu SY, Liu H, Yan HM, Xiang XX, et al. Efficacy and safety of Choudongning capsule (CDN)in children with Tourette’s syndrome of spleen deficiency and phlegm accumulation. Zhongguo Zhong Yao Za Zhi. 2016;41(16):3100–6. https://doi.org/10.4268/cjcmm20161627.

    Article  PubMed  Google Scholar 

  116. Zheng Y, Zhang ZJ, Han XM, Ding Y, Chen YY, Wang XF, et al. A proprietary herbal medicine (5-Ling Granule) for Tourette syndrome: a randomized controlled trial. J Child Psychol Psychiatry. 2016;57(1):74–83. https://doi.org/10.1111/jcpp.12432.

    Article  PubMed  Google Scholar 

  117. Hu S, Ma R, TIan T. Phase III clinical research of Changma Xifeng tablets in treating multiple tics with liver wind and sputum stirring internally (in Chinese). Drugs Clin. 2014;29(9):1044–9.

  118. Sun Q. Clinical observation on Changma Xifeng tablets in the treatment of 36 cases of Tourette’s syndrome. Management of Health Standards in China. 2016;131(2):1674–93.

    Google Scholar 

  119. Lu C, Wu LQ, Hao H, Kimberly Leow X, Xu FW, Li PP, et al. Clinical efficacy and safety of acupuncture treatment of TIC disorder in children: a systematic review and meta-analysis of 22 randomized controlled trials. Complement Ther Med. 2021;59: 102734. https://doi.org/10.1016/j.ctim.2021.102734.

    Article  PubMed  Google Scholar 

  120. Yu J, Ye Y, Liu J, Wang Y, Peng W, Liu Z. Acupuncture for Tourette syndrome: a systematic review. Evid Based Complement Alternat Med. 2016;2016:1834646. https://doi.org/10.1155/2016/1834646.

    Article  PubMed  PubMed Central  Google Scholar 

  121. Chung S, Noh B, Lee C, Hwang M, Kang M, Kwon S, et al. Acupuncture for Tourette syndrome: a systematic review and meta-analysis. Eur J Integ Med. 2016;8:809–16.

    Article  Google Scholar 

  122. Ding L, Yang Z, Liu G, Ran N, Yi M, Li H, et al. Safety and efficacy of taurine as an add-on treatment for tics in youngsters. Eur J Neurol. 2020;27(3):490–7. https://doi.org/10.1111/ene.14107.

    Article  CAS  PubMed  Google Scholar 

  123. Bond M, Moll N, Rosello A, Bond R, Schnell J, Burger B, et al. Vitamin D levels in children and adolescents with chronic tic disorders: a multicentre study. Eur Child Adolesc Psychiatry. 2021. https://doi.org/10.1007/s00787-021-01757-y.

    Article  PubMed  Google Scholar 

  124. Li HH, Shan L, Wang B, Du L, Xu ZD, Jia FY. Serum 25-hyroxyvitamin D levels and tic severity in Chinese children with tic disorders. Psychiatry Res. 2018;267:80–4. https://doi.org/10.1016/j.psychres.2018.05.066.

    Article  CAS  PubMed  Google Scholar 

  125. Li HH, Xu ZD, Wang B, Feng JY, Dong HY, Jia FY. Clinical improvement following vitamin D3 supplementation in children with chronic tic disorders. Neuropsychiatr Dis Treat. 2019;15:2443–50. https://doi.org/10.2147/NDT.S212322.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  126. Murakami J, Tachibana Y, Akiyama S, Kato T, Taniguchi A, Nakajima Y, et al. Oral splint ameliorates tic symptoms in patients with Tourette syndrome. Mov Disord. 2019;34(10):1577–8. https://doi.org/10.1002/mds.27819.

    Article  PubMed  PubMed Central  Google Scholar 

  127. Liu YW, Liong MT, Chung YE, Huang HY, Peng WS, Cheng YF et al. Effects of nutrients. 2019;11(4). doi:https://doi.org/10.3390/nu11040820.

  128. Zhao H, Shi Y, Luo X, Peng L, Yang Y, Zou L. The effect of fecal microbiota transplantation on a child with Tourette syndrome. Case Rep Med. 2017;2017:6165239. https://doi.org/10.1155/2017/6165239.

    Article  PubMed  PubMed Central  Google Scholar 

  129. Zhao HJ, Luo X, Shi YC, Li JF, Pan F, Ren RR, et al. The efficacy of fecal microbiota transplantation for children with Tourette syndrome: a preliminary study. Front Psychiatry. 2020;11: 554441. https://doi.org/10.3389/fpsyt.2020.554441.

    Article  PubMed  PubMed Central  Google Scholar 

  130. McGuire JF, Ginder N, Ramsey K, Essoe JK, Ricketts EJ, McCracken JT, et al. Optimizing behavior therapy for youth with Tourette’s disorder. Neuropsychopharmacology. 2020;45(12):2114–9. https://doi.org/10.1038/s41386-020-0762-4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  131. Fletcher J, Martino D, Pringsheim T. Novel pharmacological approaches for Tourette syndrome. Curr Dev Disord Rep. 2020;7:270–6.

    Article  Google Scholar 

  132. Chae JH, Nahas Z, Wassermann E, Li X, Sethuraman G, Gilbert D, et al. A pilot safety study of repetitive transcranial magnetic stimulation (rTMS) in Tourette’s syndrome. Cogn Behav Neurol. 2004;17(2):109–17. https://doi.org/10.1097/01.wnn.0000116253.78804.3a.

    Article  PubMed  Google Scholar 

  133. Kahl CK, Kirton A, Pringsheim T, Croarkin PE, Zewdie E, Swansburg R, et al. Bilateral transcranial magnetic stimulation of the supplementary motor area in children with Tourette syndrome. Dev Med Child Neurol. 2021;63(7):808–15. https://doi.org/10.1111/dmcn.14828.

    Article  PubMed  Google Scholar 

  134. Kwon HJ, Lim WS, Lim MH, Lee SJ, Hyun JK, Chae JH, et al. 1-Hz low frequency repetitive transcranial magnetic stimulation in children with Tourette’s syndrome. Neurosci Lett. 2011;492(1):1–4. https://doi.org/10.1016/j.neulet.2011.01.007.

    Article  CAS  PubMed  Google Scholar 

  135. Landeros-Weisenberger A, Mantovani A, Motlagh MG, de Alvarenga PG, Katsovich L, Leckman JF, et al. Randomized sham controlled double-blind trial of repetitive transcranial magnetic stimulation for adults with severe Tourette syndrome. Brain Stimul. 2015;8(3):574–81. https://doi.org/10.1016/j.brs.2014.11.015.

    Article  PubMed  Google Scholar 

  136. Le K, Liu L, Sun M, Hu L, Xiao N. Transcranial magnetic stimulation at 1 Hertz improves clinical symptoms in children with Tourette syndrome for at least 6 months. J Clin Neurosci. 2013;20(2):257–62. https://doi.org/10.1016/j.jocn.2012.01.049.

    Article  PubMed  Google Scholar 

  137. Mantovani A, Lisanby SH, Pieraccini F, Ulivelli M, Castrogiovanni P, Rossi S. Repetitive transcranial magnetic stimulation (rTMS) in the treatment of obsessive-compulsive disorder (OCD) and Tourette’s syndrome (TS). Int J Neuropsychopharmacol. 2006;9(1):95–100. https://doi.org/10.1017/S1461145705005729.

    Article  PubMed  Google Scholar 

  138. Mantovani A, Leckman JF, Grantz H, King RA, Sporn AL, Lisanby SH. Repetitive transcranial magnetic stimulation of the supplementary motor area in the treatment of Tourette syndrome: report of two cases. Clin Neurophysiol. 2007;118(10):2314–5. https://doi.org/10.1016/j.clinph.2007.07.011.

    Article  PubMed  Google Scholar 

  139. Münchau A, Bloem BR, Thilo KV, Trimble MR, Rothwell JC, Robertson MM. Repetitive transcranial magnetic stimulation for Tourette syndrome. Neurology. 2002;59(11):1789–91. https://doi.org/10.1212/01.wnl.0000036615.25044.50.

    Article  PubMed  Google Scholar 

  140. Orth M, Kirby R, Richardson MP, Snijders AH, Rothwell JC, Trimble MR, et al. Subthreshold rTMS over pre-motor cortex has no effect on tics in patients with Gilles de la Tourette syndrome. Clin Neurophysiol. 2005;116(4):764–8. https://doi.org/10.1016/j.clinph.2004.10.003.

    Article  CAS  PubMed  Google Scholar 

  141. Wu SW, Maloney T, Gilbert DL, Dixon SG, Horn PS, Huddleston DA, et al. Functional MRI-navigated repetitive transcranial magnetic stimulation over supplementary motor area in chronic tic disorders. Brain Stimul. 2014;7(2):212–8. https://doi.org/10.1016/j.brs.2013.10.005.

    Article  PubMed  Google Scholar 

  142. Fu M, Wei H, Meng X, Chen H, Shang B, Chen F, et al. Effects of low-frequency repetitive transcranial magnetic stimulation of the bilateral parietal cortex in patients with Tourette syndrome. Front Neurol. 2021;12: 602830. https://doi.org/10.3389/fneur.2021.602830.

    Article  PubMed  PubMed Central  Google Scholar 

  143. Motiwala F, Sangroula D, Ashraf S, Virk I. Repetitive transcranial magnetic stimulation for tic disorders. Curr Psych. 2018;17(6):24–5.

    Google Scholar 

  144. Hsu CW, Wang LJ, Lin PY. Efficacy of repetitive transcranial magnetic stimulation for Tourette syndrome: a systematic review and meta-analysis. Brain Stimul. 2018;11(5):1110–8. https://doi.org/10.1016/j.brs.2018.06.002.

    Article  PubMed  Google Scholar 

  145. Bloch Y, Arad S, Levkovitz Y. Deep TMS add-on treatment for intractable Tourette syndrome: a feasibility study. World J Biol Psychiatry. 2016;17(7):557–61. https://doi.org/10.3109/15622975.2014.964767.

    Article  PubMed  Google Scholar 

  146. Singh S, Kumar S, Kumar N, Verma R. Low-frequency repetitive transcranial magnetic stimulation for treatment of tourette syndrome: a naturalistic study with 3 months of follow-up. Indian J Psychol Med. 2018;40(5):482–6. https://doi.org/10.4103/IJPSYM.IJPSYM_332_17.

    Article  PubMed  PubMed Central  Google Scholar 

  147. Eapen V, Baker R, Walter A, Raghupathy V, Wehrman JJ, Sowman PF. The role of transcranial direct current stimulation (tDCS) in Tourette syndrome: a review and preliminary findings. Brain Sci. 2017;7(12). doi:https://doi.org/10.3390/brainsci7120161.

  148. Dyke K, Jackson GM, Nixon E, Jackson SR. Effects of single-session cathodal transcranial direct current stimulation on tic symptoms in Tourette’s syndrome. Exp Brain Res. 2019;237(11):2853–63. https://doi.org/10.1007/s00221-019-05637-5.

    Article  PubMed  PubMed Central  Google Scholar 

  149. Martino D, Nosratmishekarlou E, Jasaui Y, Medina A, Vicario C, Nitsche M et al. Transcranial direct current stimulation over the supplementary motor area in Tourette syndrome: preliminary findings of a randomized controlled trial. Mov Disord. 2020;35.

  150. Mrakic-Sposta S, Marceglia S, Mameli F, Dilena R, Tadini L, Priori A. Transcranial direct current stimulation in two patients with Tourette syndrome. Mov Disord. 2008;23(15):2259–61. https://doi.org/10.1002/mds.22292.

    Article  PubMed  Google Scholar 

  151. Tajadini S, Mohammadi N, Tahamtan M, Nami M. Cathodal transcranial direct current stimulation to ameliorate the frequency and severity of motor tics: a case study of Tourette syndrome. JAMSAT. 2018;4(1):21–6.

    Google Scholar 

  152. Carvalho S, Gonçalves Ó, Soares JM, Sampaio A, Macedo F, Fregni F, et al. Sustained effects of a neural-based intervention in a refractory case of Tourette syndrome. Brain Stimul. 2015;8(3):657–9. https://doi.org/10.1016/j.brs.2014.12.008.

    Article  PubMed  Google Scholar 

  153. Behler N, Leitner B, Mezger E, Weidinger E, Musil R, Blum B, et al. Cathodal tDCS over motor cortex does not improve Tourette syndrome: lessons learned from a case series. Front Behav Neurosci. 2018;12:194. https://doi.org/10.3389/fnbeh.2018.00194.

    Article  PubMed  PubMed Central  Google Scholar 

  154. Diamond A, Kenney C, Jankovic J. Effect of vagal nerve stimulation in a case of Tourette’s syndrome and complex partial epilepsy. Mov Disord. 2006;21(8):1273–5. https://doi.org/10.1002/mds.20949.

    Article  PubMed  Google Scholar 

  155. Sperling W, Reulbach U, Maihöfner C, Kornhuber J, Bleich S. Vagus nerve stimulation in a patient with Gilles de la Tourette syndrome and major depression. Pharmacopsychiatry. 2008;41(3):117–8. https://doi.org/10.1055/s-2008-1062698.

    Article  CAS  PubMed  Google Scholar 

  156. Caffery C. Transcutaneous vagal nerve stimulation & breathing exercises reduce motor and vocal tics in eleven-year-old male. Front Neurol. 2018.

  157. Münchau A, Colzato LS, AghajaniAfjedi A, Beste C. A neural noise account of Gilles de la Tourette syndrome. Neuroimage Clin. 2021;30: 102654. https://doi.org/10.1016/j.nicl.2021.102654.

    Article  PubMed  PubMed Central  Google Scholar 

  158. Morera Maiquez B, Sigurdsson HP, Dyke K, Clarke E, McGrath P, Pasche M, et al. Entraining movement-related brain oscillations to suppress tics in Tourette syndrome. Curr Biol. 2020;30(12):2334-42.e3. https://doi.org/10.1016/j.cub.2020.04.044.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  159. Morera Maiquez B, Jackson GM, Jackson SR. Examining the neural antecedents of tics in Tourette syndrome using electroencephalography. J Neuropsychol. 2021. https://doi.org/10.1111/jnp.12245.

    Article  PubMed  Google Scholar 

  160. Qiao J, Weng S, Wang P, Long J, Wang Z. Normalization of intrinsic neural circuits governing Tourette’s syndrome using cranial electrotherapy stimulation. IEEE Trans Biomed Eng. 2015;62(5):1272–80. https://doi.org/10.1109/TBME.2014.2385151.

    Article  PubMed  Google Scholar 

  161. Deeb W, Leentjens AFG, Mogilner AY, Servello D, Meng F, Zhang J, et al. Deep brain stimulation lead removal in Tourette syndrome. Parkinsonism Relat Disord. 2020;77:89–93. https://doi.org/10.1016/j.parkreldis.2020.06.025.

    Article  PubMed  Google Scholar 

  162. Schrock LE, Mink JW, Woods DW, Porta M, Servello D, Visser-Vandewalle V et al. Tourette syndrome deep brain stimulation: a review and updated recommendations. Mov Disord. 2015;30(4):448-71. doi:https://doi.org/10.1002/mds.26094. 

  163. •• Martino D, Deeb W, Jimenez-Shahed J, Malaty I, Pringsheim TM, Fasano A, et al. The 5 pillars in Tourette syndrome deep brain stimulation patient selection: present and future. Neurology. 2021;96(14):664–76. https://doi.org/10.1212/WNL.0000000000011704. Important guideline updates for how to select patients with TS for DBS treatment

  164. Deeb W, Malaty I. Deep brain stimulation for Tourette syndrome: potential role in the pediatric population. J Child Neurol. 2020;35(2):155–65. https://doi.org/10.1177/0883073819872620.

    Article  PubMed  Google Scholar 

  165. Hauseux PA, Cyprien F, Cif L, Gonzalez V, Boulenger JP, Coubes P et al. Long-term follow-up of pallidal deep brain stimulation in teenagers with refractory Tourette syndrome and comorbid psychiatric disorders: about three cases. Eur J Paediatr Neurol. 2017;21(1):214–7. doi:https://doi.org/10.1016/j.ejpn.2016.06.005. 

  166. • Coulombe MA, Elkaim LM, Alotaibi NM, Gorman DA, Weil AG, Fallah A, et al. Deep brain stimulation for Gilles de la Tourette syndrome in children and youth: a meta-analysis with individual participant data. J Neurosurg Pediatr. 2018;23(2):236–46. https://doi.org/10.3171/2018.7.PEDS18300. Good overview of the safety and efficacy of DBS for TS

  167. Casagrande SCB, Cury RG, Alho EJL, Fonoff ET. Deep brain stimulation in Tourette’s syndrome: evidence to date. Neuropsychiatr Dis Treat. 2019;15:1061–75. https://doi.org/10.2147/NDT.S139368.

    Article  PubMed  PubMed Central  Google Scholar 

  168. Deeb W, Rossi PJ, Porta M, Visser-Vandewalle V, Servello D, Silburn P, et al. The International Deep Brain Stimulation Registry and Database for Gilles de la Tourette Syndrome: how does it work? Front Neurosci. 2016;10:170. https://doi.org/10.3389/fnins.2016.00170.

    Article  PubMed  PubMed Central  Google Scholar 

  169. Akbarian-Tefaghi L, Zrinzo L, Foltynie T. The use of deep brain stimulation in Tourette syndrome. Brain Sci. 2016;6(3). doi:https://doi.org/10.3390/brainsci6030035.

  170. Xu W, Zhang C, Deeb W, Patel B, Wu Y, Voon V, et al. Deep brain stimulation for Tourette’s syndrome. Transl Neurodegener. 2020;9:4. https://doi.org/10.1186/s40035-020-0183-7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  171. Servello D, Galbiati TF, Balestrino R, Iess G, Zekaj E, Michele S et al. Deep brain stimulation for Gilles de la Tourette syndrome: toward limbic targets. Brain Sci. 2020;10(5). doi:https://doi.org/10.3390/brainsci10050301.

  172. Baldermann JC, Schüller T, Huys D, Becker I, Timmermann L, Jessen F, et al. Deep brain stimulation for Tourette-syndrome: a systematic review and meta-analysis. Brain Stimul. 2016;9(2):296–304. https://doi.org/10.1016/j.brs.2015.11.005.

    Article  PubMed  Google Scholar 

  173. Huys D, Bartsch C, Koester P, Lenartz D, Maarouf M, Daumann J, et al. Motor improvement and emotional stabilization in patients with Tourette syndrome after deep brain stimulation of the ventral anterior and ventrolateral motor part of the thalamus. Biol Psychiatry. 2016;79(5):392–401. https://doi.org/10.1016/j.biopsych.2014.05.014.

    Article  PubMed  Google Scholar 

  174. Rossi PJ, Opri E, Shute JB, Molina R, Bowers D, Ward H, et al. Scheduled, intermittent stimulation of the thalamus reduces tics in Tourette syndrome. Parkinsonism Relat Disord. 2016;29:35–41. https://doi.org/10.1016/j.parkreldis.2016.05.033.

    Article  PubMed  PubMed Central  Google Scholar 

  175. Schoenberg MR, Maddux BN, Riley DE, Whitney CM, Ogrocki PK, Gould D, et al. Five-months-postoperative neuropsychological outcome from a pilot prospective randomized clinical trial of thalamic deep brain stimulation for Tourette syndrome. Neuromodulation. 2015;18(2):97–104. https://doi.org/10.1111/ner.12233.

  176. Servello D, Zekaj E, Saleh C, Lange N, Porta M. Deep brain stimulation in Gilles de la Tourette syndrome: what does the future hold? A cohort of 48 patients. Neurosurgery. 2016;78(1):91–100. https://doi.org/10.1227/NEU.0000000000001004.

    Article  PubMed  Google Scholar 

  177. Okun MS, Foote KD, Wu SS, Ward HE, Bowers D, Rodriguez RL, et al. A trial of scheduled deep brain stimulation for Tourette syndrome: moving away from continuous deep brain stimulation paradigms. JAMA Neurol. 2013;70(1):85–94. https://doi.org/10.1001/jamaneurol.2013.580.

    Article  PubMed  Google Scholar 

  178. Ackermans L, Duits A, van der Linden C, Tijssen M, Schruers K, Temel Y, et al. Double-blind clinical trial of thalamic stimulation in patients with Tourette syndrome. Brain. 2011;134(Pt 3):832–44. https://doi.org/10.1093/brain/awq380.

    Article  PubMed  Google Scholar 

  179. Kefalopoulou Z, Zrinzo L, Jahanshahi M, Candelario J, Milabo C, Beigi M, et al. Bilateral globus pallidus stimulation for severe Tourette’s syndrome: a double-blind, randomised crossover trial. Lancet Neurol. 2015;14(6):595–605. https://doi.org/10.1016/S1474-4422(15)00008-3.

    Article  PubMed  Google Scholar 

  180. Welter ML, Houeto JL, Thobois S, Bataille B, Guenot M, Worbe Y, et al. Anterior pallidal deep brain stimulation for Tourette’s syndrome: a randomised, double-blind, controlled trial. Lancet Neurol. 2017;16(8):610–9. https://doi.org/10.1016/S1474-4422(17)30160-6.

    Article  PubMed  Google Scholar 

  181. Baldermann JC, Kuhn J, Schüller T, Kohl S, Andrade P, Schleyken S, et al. Thalamic deep brain stimulation for Tourette syndrome: a naturalistic trial with brief randomized, double-blinded sham-controlled periods. Brain Stimul. 2021;14(5):1059–67. https://doi.org/10.1016/j.brs.2021.07.003.

    Article  PubMed  Google Scholar 

  182. Welter ML, Mallet L, Houeto JL, Karachi C, Czernecki V, Cornu P, et al. Internal pallidal and thalamic stimulation in patients with Tourette syndrome. Arch Neurol. 2008;65(7):952–7. https://doi.org/10.1001/archneur.65.7.952.

    Article  PubMed  Google Scholar 

  183. Marceglia S, Rosa M, Servello D, Porta M, Barbieri S, Moro E et al. Adaptive deep brain stimulation (aDBS) for Tourette syndrome. Brain Sci. 2017;8(1). doi:https://doi.org/10.3390/brainsci8010004.

  184. Neumann WJ, Huebl J, Brücke C, Lofredi R, Horn A, Saryyeva A, et al. Pallidal and thalamic neural oscillatory patterns in Tourette’s syndrome. Ann Neurol. 2018;84(4):505–14. https://doi.org/10.1002/ana.25311.

    Article  PubMed  Google Scholar 

  185. Molina R, Okun MS, Shute JB, Opri E, Rossi PJ, Martinez-Ramirez D, et al. Report of a patient undergoing chronic responsive deep brain stimulation for Tourette syndrome: proof of concept. J Neurosurg. 2018;129(2):308–14. https://doi.org/10.3171/2017.6.JNS17626.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Fixel Institute for Neurological Diseases, University of Florida, Gainesville, FL, USA

    Jessica Frey & Irene A. Malaty

Authors
  1. Jessica Frey
    View author publications

    Search author on:PubMed Google Scholar

  2. Irene A. Malaty
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Irene A. Malaty.

Ethics declarations

Conflict of Interest

The authors have no disclosures to report relevant to the content of this paper.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Movement Disorders

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Frey, J., Malaty, I.A. Tourette Syndrome Treatment Updates: a Review and Discussion of the Current and Upcoming Literature. Curr Neurol Neurosci Rep 22, 123–142 (2022). https://doi.org/10.1007/s11910-022-01177-8

Download citation

  • Accepted:

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1007/s11910-022-01177-8

Keywords

Profiles

  1. Irene A. Malaty View author profile